X

Vous n'êtes pas connecté

  - NEWS.MEDICAL.NET - A la Une - 17/Jan 07:27

Unveiling the metabolic pathways of Fusobacterium nucleatum in OSCC

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell carcinoma (OSCC). By identifying key interactions between this common oral bacterium and host cells, the research has unveiled important metabolic pathways and mechanisms that may serve as potential therapeutic targets.

Articles similaires

Fusobacterium nucleatum in colorectal cancer: Ally mechanism and targeted therapy strategies

oncologynews.com.au - 23/Jun 18:48

In recent years, the regulatory role of the gut microbiota in the initiation and progression of colorectal cancer (CRC) has attracted growing...

Sorry! Image not available at this time

Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer

drugs.com - 27/Jun 15:06

FRIDAY, June 27, 2025 -- For patients with locally advanced head and neck squamous cell carcinoma (HNSCC), the addition of neoadjuvant and adjuvant...

Sorry! Image not available at this time

Adding Pembrolizumab to Standard Care Ups Event-Free Survival in Head, Neck Cancer

drugs.com - 27/Jun 15:06

FRIDAY, June 27, 2025 -- For patients with locally advanced head and neck squamous cell carcinoma (HNSCC), the addition of neoadjuvant and adjuvant...

IGF2BP1: a critical driver of cancer progression and therapeutic target

oncologynews.com.au - 30/Jun 18:31

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and...

IGF2BP1: a critical driver of cancer progression and therapeutic target

oncologynews.com.au - 30/Jun 18:31

The RNA-binding protein IGF2BP1 has emerged as a key regulator of cancer hallmarks, influencing tumour proliferation, metastasis, immune evasion, and...

Melbourne company wins stem cell manufacturing licence in Australian first

aumanufacturing.com.au - 23/Jun 01:12

A Melbourne biotechnology company has become one of the first in Australasia to receive a licence to manufacture stem cells, potentially reducing...

Sorry! Image not available at this time

Kombucha can rebalance gut ecosystem in people with obesity: study

wn.com - 29/Jun 00:51

In a human trial, kombucha appeared to nudge the gut microbiome in directions associated with better metabolic health after two months ......

Sorry! Image not available at this time

Kombucha can rebalance gut ecosystem in people with obesity: study

wn.com - 29/Jun 00:51

In a human trial, kombucha appeared to nudge the gut microbiome in directions associated with better metabolic health after two months ......

Mitochondrial ribosomal protein family in cancers: Mechanistic insights and therapeutic implications

oncologynews.com.au - 30/Jun 18:09

This review is collaboratively prepared by Prof. Yingli Zhang (Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences), Prof. Jin-Jian Lu,...

Mitochondrial ribosomal protein family in cancers: Mechanistic insights and therapeutic implications

oncologynews.com.au - 30/Jun 18:09

This review is collaboratively prepared by Prof. Yingli Zhang (Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences), Prof. Jin-Jian Lu,...

Les derniers communiqués

  • Aucun élément